Research Article
Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study
Figure 6
DPSC secretome degrades Aβ1–42 protein in vitro. (a) Immunoblotting analysis at each time point with an anti-Aβ antibody (full-length blots are presented in Supplementary Figure S4). (b) Quantitation of remaining Aβ1–42 level (mean ± SE).
| (a) |
| (b) |